{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:10:15Z","timestamp":1795173015139,"version":"4.10.3"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The existing guidelines for PsA cover many aspects of management. Some gaps remain relating to routine practice application. An expert group aimed to enhance the current guidance and develop recommendations for clinical practice that are complementary to the existing guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A steering committee comprising experienced, research-active clinicians in rheumatology, dermatology and primary care agreed on themes and relevant questions. A targeted literature review of PubMed and Embase following a PICO framework was conducted. At a second meeting, recommendations were drafted, and subsequently an extended faculty comprising rheumatologists, dermatologists, primary care clinicians, specialist nurses, allied health professionals, non-clinical academic participants and members of the Brit-PACT patient group, was recruited. Consensus was achieved via an online voting platform at which 75% of respondents agreed in the range of 7\u20139 on a 9-point scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The guidance comprised 34 statements covering four PsA themes. Diagnosis focused on strategies for identifying PsA early and referring appropriately, assessment of diagnostic indicators, use of screening tools and use of imaging. Disease assessment centred on holistic consideration of disease activity, physical functioning and impact from a patient perspective, and on how to implement shared decision-making. For comorbidities, recommendations included specific guidance on high-impact conditions such as depression and obesity. Management statements (which excluded extant guidance on pharmacological therapies) recommended multidisciplinary team working, implementation of lifestyle modifications and treat-to-target strategies. Minimizing CS use was recommended where feasible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The consensus group have made evidence-based best-practice recommendations for the management of PsA to enhance the existing guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae172","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T02:46:15Z","timestamp":1710297975000},"page":"561-573","source":"Crossref","is-referenced-by-count":11,"title":["Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-663X","authenticated-orcid":false,"given":"Laura C","family":"Coates","sequence":"first","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Bukhari","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Lancaster Infirmary , Lancaster,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2323-8161","authenticated-orcid":false,"given":"Antoni","family":"Chan","sequence":"additional","affiliation":[{"name":"University Department of Rheumatology, Royal Berkshire NHS Foundation Trust , Reading,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-8609","authenticated-orcid":false,"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[{"name":"Cardiff Regional Experimental Arthritis Treatment and Evaluation (CREATE) Centre, Cardiff University , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1230-2781","authenticated-orcid":false,"given":"James","family":"Galloway","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King\u2019s College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8970-4116","authenticated-orcid":false,"given":"Nicola","family":"Gullick","sequence":"additional","affiliation":[{"name":"Rheumatology Department, University Hospitals of Coventry & Warwickshire , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Kent","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Salisbury NHS Foundation Trust , Salisbury,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine and Health, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-7311","authenticated-orcid":false,"given":"Stefan","family":"Siebert","sequence":"additional","affiliation":[{"name":"School of Infection and Immunity, University of Glasgow , Glasgow,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tillett","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Royal National Hospital for Rheumatic Disease , Bath,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Wood","sequence":"additional","affiliation":[{"name":"The Wooda Surgery , Bideford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-5665","authenticated-orcid":false,"given":"Philip G","family":"Conaghan","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"2025032905210456600_keae172-B1","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1093\/rheumatology\/keac295","article-title":"The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs","volume":"61","author":"Tucker","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"key":"2025032905210456600_keae172-B2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic arthritis: state of the art review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med Lond Engl"},{"key":"2025032905210456600_keae172-B3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40744-020-00221-8","article-title":"Disease characteristics and the burden of joint and skin involvement amongst people with psoriatic arthritis: a population survey","volume":"7","author":"Tillett","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2025032905210456600_keae172-B4","doi-asserted-by":"crossref","first-page":"rkab042","DOI":"10.1093\/rap\/rkab042","article-title":"Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UK","volume":"5","author":"Cooksey","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2025032905210456600_keae172-B5","doi-asserted-by":"crossref","first-page":"1054539","DOI":"10.3389\/fimmu.2022.1054539","article-title":"Biomarkers in psoriatic arthritis: a meta-analysis and systematic review","volume":"13","author":"Wirth","year":"2022","journal-title":"Front Immunol"},{"key":"2025032905210456600_keae172-B6","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/S0140-6736(18)30949-8","article-title":"Clinical management of psoriatic arthritis","volume":"391","author":"Van den Bosch","year":"2018","journal-title":"Lancet"},{"key":"2025032905210456600_keae172-B7","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","article-title":"Treatment guidelines in psoriatic arthritis","volume":"59","author":"Ogdie","year":"2020","journal-title":"Rheumatology"},{"key":"2025032905210456600_keae172-B8","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001975","article-title":"Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany","volume":"7","author":"Deike","year":"2021","journal-title":"RMD Open"},{"key":"2025032905210456600_keae172-B9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjd.18227","article-title":"Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis","volume":"182","author":"Green","year":"2020","journal-title":"Br J Dermatol"},{"key":"2025032905210456600_keae172-B10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025032905210456600_keae172-B11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2021.09.019","article-title":"Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: retrospective analysis of an electronic health records database in the United States","volume":"86","author":"Merola","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2025032905210456600_keae172-B12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.semarthrit.2021.03.007","article-title":"Axial disease in psoriatic arthritis: the presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort","volume":"51","author":"Feld","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905210456600_keae172-B13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2340\/00015555-2912","article-title":"Duration of psoriatic skin disease as risk factor for subsequent onset of psoriatic arthritis","volume":"98","author":"Egeberg","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"2025032905210456600_keae172-B14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jid.2016.11.032","article-title":"Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study","volume":"137","author":"Lewinson","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2025032905210456600_keae172-B15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2019.05.075","article-title":"Measuring psoriatic arthritis symptoms: a core domain in psoriasis clinical trials","volume":"82","author":"Perez-Chada","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025032905210456600_keae172-B16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000448029","article-title":"Sensitivity of the GEPARD patient questionnaire to identify psoriatic arthritis in patients with psoriasis in daily practice: the GEPARD-life study","volume":"232","author":"H\u00e4rle","year":"2016","journal-title":"Dermatol Basel Switz"},{"key":"2025032905210456600_keae172-B17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/bjd.14929","article-title":"Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study)","volume":"176","author":"Mishra","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025032905210456600_keae172-B18","author":"National Institute for Health and Care Excellence"},{"key":"2025032905210456600_keae172-B19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/rheumatology\/key314","article-title":"Psoriatic arthritis screening: a systematic review and meta-analysis","volume":"58","author":"Iragorri","year":"2019","journal-title":"Rheumatology"},{"key":"2025032905210456600_keae172-B20"},{"key":"2025032905210456600_keae172-B21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3899\/jrheum.201199","article-title":"Diagnostic delay in psoriatic arthritis: a population-based study","volume":"48","author":"Karmacharya","year":"2021","journal-title":"J Rheumatol"},{"key":"2025032905210456600_keae172-B22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025032905210456600_keae172-B23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00403-019-01906-z","article-title":"Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)","volume":"311","author":"Duvetorp","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"2025032905210456600_keae172-B24","doi-asserted-by":"crossref","first-page":"737079","DOI":"10.3389\/fmed.2021.737079","article-title":"Extra-articular manifestations and comorbidities in psoriatic disease: a journey into the immunologic crosstalk","volume":"8","author":"Novelli","year":"2021","journal-title":"Front Med"},{"key":"2025032905210456600_keae172-B25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3899\/jrheum.220154","article-title":"Women with psoriatic arthritis experience higher disease burden than men: findings from a real-world survey in the United States and Europe","volume":"50","author":"Gossec","year":"2023","journal-title":"J Rheumatol"},{"key":"2025032905210456600_keae172-B26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3892\/etm.2020.9332","article-title":"Implications of self-esteem in the quality of life in patients with psoriasis","volume":"20","author":"Brihan","year":"2020","journal-title":"Exp Ther Med"},{"key":"2025032905210456600_keae172-B27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/TCRM.S101619","article-title":"The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version","volume":"12","author":"Salaffi","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"2025032905210456600_keae172-B28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.23568","article-title":"Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis","volume":"59","author":"Healy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025032905210456600_keae172-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573397111666150522093712","article-title":"Development and validation of a Patient Reported Experience Measure (PREM) for patients with rheumatoid arthritis (RA) and other rheumatic conditions","volume":"11","author":"Bosworth","year":"2015","journal-title":"Curr Rheumatol Rev"},{"key":"2025032905210456600_keae172-B30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025032905210456600_keae172-B31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/acr.24121","article-title":"Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway","volume":"73","author":"Thomsen","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2025032905210456600_keae172-B32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1756-185X.13987","article-title":"Fibromyalgia in patients with psoriatic arthritis: impact on disease activity indices, fatigue and health-related quality of life","volume":"24","author":"Elsawy","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2025032905210456600_keae172-B33","first-page":"426","article-title":"Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA Treatment Recommendations","volume":"50","author":"Campanholo","year":"2023","journal-title":"J Rheumatol"},{"key":"2025032905210456600_keae172-B34","author":"National Institute for Health and Care Excellence"},{"key":"2025032905210456600_keae172-B35","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2012-202812","article-title":"Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor \u03b1 blockers","volume":"73","author":"Di Minno","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025032905210456600_keae172-B36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025032905210456600_keae172-B37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","article-title":"2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases","volume":"82","author":"Gwinnutt","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025032905210456600_keae172-B38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"29","author":"Visseren","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2025032905210456600_keae172-B39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jdv.12024","article-title":"Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis","volume":"27","author":"Daud\u00e9n","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025032905210456600_keae172-B40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00296-019-04253-4","article-title":"Early arthritis clinic is effective for rheumatoid and psoriatic arthritides","volume":"39","author":"Nisar","year":"2019","journal-title":"Rheumatol Int"},{"key":"2025032905210456600_keae172-B41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"Acosta Felquer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025032905210456600_keae172-B42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jbspin.2015.01.016","article-title":"Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: a prospective study","volume":"82","author":"Acquacalda","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"Suppl 9","key":"2025032905210456600_keae172-B43","article-title":"Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a nested matched cohort study from within the UK National Early Inflammatory Arthritis Audit","volume":"74","author":"Charlton","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025032905210456600_keae172-B44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","article-title":"Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study","volume":"42","author":"McHugh","year":"2003","journal-title":"Rheumatology"},{"key":"2025032905210456600_keae172-B45"},{"key":"2025032905210456600_keae172-B46","doi-asserted-by":"crossref","first-page":"adv00324","DOI":"10.2340\/00015555-3682","article-title":"Incidence of psoriatic arthritis in patients with skin psoriasis and associated risk factors: a retrospective population-based cohort study in Swedish routine clinical care","volume":"100","author":"Lindberg","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2025032905210456600_keae172-B47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.23614","article-title":"Impact of high-intensity interval training on disease activity and disease in patients with psoriatic arthritis: a randomized controlled trial","volume":"71","author":"Thomsen","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2025032905210456600_keae172-B48","doi-asserted-by":"crossref","first-page":"rkaa076","DOI":"10.1093\/rap\/rkaa076","article-title":"Patient perceptions of co-morbidities in inflammatory arthritis","volume":"5","author":"Koduri","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2025032905210456600_keae172-B49","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025032905210456600_keae172-B50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025032905210456600_keae172-B51","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae172\/58695194\/keae172.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/561\/58695194\/keae172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/561\/58695194\/keae172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T23:27:56Z","timestamp":1743377276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/561\/7629161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae172","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,3,15]]}}}